Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #NU 23H06: A Phase II Multi-Center Open-Label Trial of Six Doses of Pembrolizumab Monotherapy Prior to Limited Chemotherapy as Front-Line Therapy for Patients with Classical Hodgkin Lymphoma, Including Elderly Patients
Winter, Jane Norma
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
1/29/24
→
1/29/27
Funding
Merck Sharp & Dohme LLC
(Prot #NU 23H06)
View all
View less